| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 13,600 | 14,200 | 08.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11.25 | Orthofix auf der Stifel-Konferenz 2025: Strategisches Wachstum und Herausforderungen | 1 | Investing.com Deutsch | ||
| 11.11.25 | Orthofix stellt auf UBS Global Healthcare Conference strategische Weichen für Wachstum | - | Investing.com Deutsch | ||
| 04.11.25 | Orthofix Q3 2025 slides: Sales up 6.3%, EBITDA margins improve despite net loss | 1 | Investing.com | ||
| 04.11.25 | Earnings Call Transkript: Orthofix verfehlt im Q3 2025 die Gewinnerwartung, übertrifft aber den Umsatz | - | Investing.com Deutsch | ||
| ORTHOFIX MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.11.25 | Orthofix Medical Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 04.11.25 | Orthofix Medical reports mixed Q3 results; narrows FY outlook | 1 | Seeking Alpha | ||
| 04.11.25 | Orthofix Medical Inc. - 8-K, Current Report | - | SEC Filings | ||
| 03.11.25 | Insights Ahead: Orthofix Medical's Quarterly Earnings | 1 | Benzinga.com | ||
| 22.10.25 | SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S. | 400 | Business Wire | Orthofix is a global medical technology company focused on healing musculoskeletal pathologies The distribution arrangement is part of SMAIO's collaborative strategy aimed at deploying... ► Artikel lesen | |
| 05.08.25 | Orthofix Q2 2025 slides: Positive free cash flow achieved amid strong U.S. growth | 1 | Investing.com | ||
| 05.08.25 | Orthofix stock rises on Street-beating Q2 | 2 | MassDevice | ||
| 05.08.25 | Orthofix anticipates full-year net sales of $808M-$816M while accelerating U.S. spine distributor transition | 1 | Seeking Alpha | ||
| 05.08.25 | Orthofix Medical Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 05.08.25 | Orthofix Medical Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| MEDTRONIC | 85,28 | -0,15 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,40 | -0,97 % | Is ISRG Stock Still A Buy At $600? | ||
| THERMO FISHER | 520,10 | -1,55 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| TELADOC HEALTH | 6,496 | +0,15 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| ROKU | 93,64 | -0,82 % | Evercore ISI upgrades Roku stock rating to Outperform on 2026 catalysts | ||
| BECTON DICKINSON | 175,00 | +0,81 % | Stifel raises Becton Dickinson stock price target to $215 from $210 | ||
| DEXCOM | 58,09 | -3,20 % | Dexcom touts future at CES with new CEO Leach now leading | ||
| BOSTON SCIENTIFIC | 84,60 | +0,24 % | Boston Scientific reportedly plans to consolidate some Texas operations with new facility | ||
| RESMED | 215,00 | +1,18 % | Is This the Right Time to Add Resmed Stock to Your Portfolio? | ||
| INMODE | 12,300 | -8,24 % | InMode Q4 Preliminary Revenue Rises | ||
| BAXTER | 17,700 | +1,36 % | MUSC Health und Baxter gehen strategische Partnerschaft für vernetzte Medizintechnik ein |